Lv62
2780 积分 2022-03-19 加入
苦逼的很
A reality check for autoimmune CAR T cells
6天前
已完结
Translation of in vivo CAR-T in China
13天前
已完结
Toward the next generation of CAR T cell therapies for cancer
24天前
已关闭
Rapid CAR-T manufacturing with low-intensity priming enhances CAR-T cell fitness and limits inflammatory programming in a phase 1 study
24天前
已完结
Autotransduction and Pseudotyping as a Key Limitations in Lentiviral Vector Production
1个月前
已完结
In vivo CAR T-cell therapy: determinants of response and durability
1个月前
已完结
mRNA-encoding CD19-targeting T cell engager for refractory immune thrombocytopenia
1个月前
已完结
The landscape for in vivo CAR T cell therapies
1个月前
已完结
Decade-long persistence of CD19 CAR T cells in B cell lymphomas
1个月前
已完结
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
1个月前
已完结
皖公网安备34019202002308
